ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years
Philippe A. Soyer
Matched on ORCID iD 0000-0002-5055-1682; OpenAlex author ID A5089984534. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 2 papers
Papers 6
- Radiomics in Early Detection of Pancreatic Ductal Adenocarcinoma: A Close Look at Its Current Status and Challenges to Clinical Implementation. Co-author DOI 10.1177/08465371251351810↗
- Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomography. Last author DOI 10.1177/08465371261426959↗
- Imaging of Pancreatic Ductal Adenocarcinoma: An Update on Recent Advances. Last author DOI 10.1177/08465371221124927↗
- Interobserver Variability and Accuracy of Preoperative CT and MRI in Pancreatic Ductal Adenocarcinoma Size Estimation: A Retrospective Cohort Study. Last author DOI 10.1177/08465371221137885↗
- Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy. Co-author DOI 10.3390/cancers14246179↗
- Utility of CT to Differentiate Pancreatic Parenchymal Metastasis from Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers13133103↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maxime Barat · 5 shared papers, 2021–2026 · strength 0.89
- Paper Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomograp… DOI 10.1177/08465371261426959↗
- Paper Imaging of Pancreatic Ductal Adenocarcinoma: An Update on Recent Advances. DOI 10.1177/08465371221124927↗
- Paper Interobserver Variability and Accuracy of Preoperative CT and MRI in Pancreatic Ductal Adenocarcinoma Size Estimation: … DOI 10.1177/08465371221137885↗
- Ugo Marchèse · 5 shared papers, 2021–2026 · strength 0.89
- Paper Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomograp… DOI 10.1177/08465371261426959↗
- Paper Imaging of Pancreatic Ductal Adenocarcinoma: An Update on Recent Advances. DOI 10.1177/08465371221124927↗
- Paper Interobserver Variability and Accuracy of Preoperative CT and MRI in Pancreatic Ductal Adenocarcinoma Size Estimation: … DOI 10.1177/08465371221137885↗
- Romain Coriat · 5 shared papers, 2021–2026 · strength 0.89
- Paper Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomograp… DOI 10.1177/08465371261426959↗
- Paper Imaging of Pancreatic Ductal Adenocarcinoma: An Update on Recent Advances. DOI 10.1177/08465371221124927↗
- Paper Interobserver Variability and Accuracy of Preoperative CT and MRI in Pancreatic Ductal Adenocarcinoma Size Estimation: … DOI 10.1177/08465371221137885↗
- Anna Pellat · 3 shared papers, 2022–2026 · strength 0.60
- Paper Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomograp… DOI 10.1177/08465371261426959↗
- Paper Imaging of Pancreatic Ductal Adenocarcinoma: An Update on Recent Advances. DOI 10.1177/08465371221124927↗
- Paper Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as… DOI 10.3390/cancers14246179↗
- Elliot K. Fishman · 2 shared papers, 2023–2026 · strength 0.51
- Linda Chi Hang Chu · 2 shared papers, 2023–2026 · strength 0.51
- Hajra Arshad · 1 shared paper, 2026 · strength 0.33
- Felipe Lopez-Ramirez · 1 shared paper, 2026 · strength 0.33
- Florent Tixier · 1 shared paper, 2026 · strength 0.33
- Satomi Kawamoto · 1 shared paper, 2026 · strength 0.33
- Marwa Alkatheeri · 1 shared paper, 2026 · strength 0.27
- Thị Thùy Linh Nguyễn · 1 shared paper, 2026 · strength 0.27
- Christophe Cassinotto · 1 shared paper, 2023 · strength 0.18
- Romain Cocquempot · 1 shared paper, 2023 · strength 0.17
- Victor Mortier · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.